JP2009526861A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009526861A5 JP2009526861A5 JP2008555380A JP2008555380A JP2009526861A5 JP 2009526861 A5 JP2009526861 A5 JP 2009526861A5 JP 2008555380 A JP2008555380 A JP 2008555380A JP 2008555380 A JP2008555380 A JP 2008555380A JP 2009526861 A5 JP2009526861 A5 JP 2009526861A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- lec3
- ednra
- cxcr4
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77299106P | 2006-02-14 | 2006-02-14 | |
| PCT/US2007/004114 WO2007095353A2 (en) | 2006-02-14 | 2007-02-14 | Gpcrs as angiogenesis targets |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009526861A JP2009526861A (ja) | 2009-07-23 |
| JP2009526861A5 true JP2009526861A5 (https=) | 2010-04-02 |
Family
ID=38372149
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008555380A Pending JP2009526861A (ja) | 2006-02-14 | 2007-02-14 | 血管新生標的としてのgpcr |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1996619A4 (https=) |
| JP (1) | JP2009526861A (https=) |
| WO (1) | WO2007095353A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107073078B (zh) * | 2014-09-26 | 2021-07-06 | 赫利世弥斯株式会社 | 利用肝细胞生长因子和基质细胞衍生因子1α的用于预防或治疗外周动脉疾病的组合物 |
| FR3077574B1 (fr) | 2018-02-07 | 2022-04-01 | Commissariat Energie Atomique | Anticorps dirige contre le sous-type a des recepteurs aux endothelines et ses utilisations. |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2128208C (en) * | 1992-11-17 | 2004-01-06 | Ronald Godiska | Novel seven transmembrane receptors |
| EP0854918A1 (en) * | 1996-01-30 | 1998-07-29 | The National Institutes of Health | Cells expressing both human cd4 and cxcr4 |
| US6479256B1 (en) * | 1998-03-04 | 2002-11-12 | Icos Corporation | Lectomedin materials and methods |
| WO1999047158A2 (en) * | 1998-03-13 | 1999-09-23 | The University Of British Columbia | Therapeutic chemokine receptor antagonists |
| US20020107196A1 (en) * | 1998-07-21 | 2002-08-08 | Smithkline Beecham Corporation | Method for inducing chemotaxis in endothelial cells by administering stromal cell derived factor-1alpha |
| WO2002079492A2 (en) * | 2001-02-14 | 2002-10-10 | Protein Design Labs, Inc. | Methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators |
| US20040009171A1 (en) * | 2001-10-18 | 2004-01-15 | Genentech, Inc. | Methods for the treatment of carcinoma |
-
2007
- 2007-02-14 EP EP07750916A patent/EP1996619A4/en not_active Withdrawn
- 2007-02-14 JP JP2008555380A patent/JP2009526861A/ja active Pending
- 2007-02-14 WO PCT/US2007/004114 patent/WO2007095353A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2363162T3 (es) | Composicones y procedimientos para el tratamiento de trastornos fibróticos. | |
| RU2411042C2 (ru) | Композиции и способы для лечения острого респираторного синдрома (sars) | |
| CN115850387B (zh) | 超高亲和力的靶向pd-l1的小蛋白及药物组合物 | |
| WO2006023791A2 (en) | Methods and compositions for treating allergic inflammation | |
| JPH06506596A (ja) | インターロイキン−8受容体及び関連分子及び方法 | |
| WO2008103849A4 (en) | Methods and compounds for lymphoma cell detection and isolation | |
| CN101553501A (zh) | Il-21变种 | |
| CN102180969B (zh) | 抗肝癌活性单克隆抗体及其应用 | |
| WO2013072901A2 (en) | Compositions and methods for treating glioma | |
| US6689878B2 (en) | Target of RNAIII activating protein (TRAP) | |
| JP2008517900A5 (https=) | ||
| CN112870362B (zh) | Circ-MET-1214和/或Circ-M50作为靶点在制备抗肿瘤药物中的用途 | |
| CZ303409B6 (cs) | Zkrácený a mutovaný lidský chemokin | |
| KR20190123934A (ko) | 신규한 중증열성혈소판감소증후군 바이러스 | |
| JP2009526861A5 (https=) | ||
| US11117976B2 (en) | Compositions and methods for regulating erythropoiesis | |
| CN105143256A (zh) | 血管生成素-2特异性Tie2受体 | |
| US20080194467A1 (en) | Cancer treatment methods using cadherin antagonists in combination with anticancer agents | |
| CN116253775B (zh) | 靶向抑制slug转录激活作用的多肽及其用途 | |
| US20160031937A1 (en) | Neural regeneration peptides and uses therefor | |
| CN117683094A (zh) | 一种硬骨素结合环肽及其应用 | |
| JP2008504248A5 (https=) | ||
| EP1188831B1 (en) | Target of RNAIII activating protein (TRAP) | |
| KR20200005165A (ko) | 신규한 중증열성혈소판감소증후군 바이러스 | |
| KR102097989B1 (ko) | 신규한 중증열성혈소판감소증후군 바이러스 |